Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

S0010 506U78 in Treating Patients With Recurrent or Refractory Acute Lymphocytic Leukemia

This study has been completed.
National Cancer Institute (NCI)
Information provided by (Responsible Party):
Southwest Oncology Group Identifier:
First received: July 5, 2000
Last updated: March 5, 2015
Last verified: March 2015
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: July 2004
  Primary Completion Date: June 2004 (Final data collection date for primary outcome measure)